On the occasion of World Menstrual Hygiene Day, MildCares, a start-up incubated by the Startup Incubation and Innovation Centre (SIIC), IIT Kanpur, achieved a landmark feat by distributing their GynoCup Menstrual Cups in Aminabad Urf Baragoan village. This initiative successfully transitione
In a major feat, the Serum Institute of India (SII) has shipped its first set of R21/Matrix-M Malaria vaccine doses to the Africa region, which has a sizable disease burden.
"With India achieving high vaccination rates in 2021 and 2022, coupled with the emergence of new mutant variant strains, the demand for previous vaccines diminished significantly. Consequently, since December 2021, we have stopped the manufacturing and supply of additional doses of Covishiel
Amid the ongoing fighting in the Rakhine state and other areas, the Ministry of External Affairs said on Friday that the security situation in Myanmar remains precarious and deteriorating.
Mumbai (Maharashtra) [India], March 22: In a world where sustainability is paramount, R. World Institutional Ranking has taken a pioneering step towards recognizing and promoting institutions committed to environmental, social, and economic sustainability in India. With the belief that human
While addressing people at an award programme in Pune, Maharashtra, on Wednesday, where Cyrus Poonawala was also present, Sharad Pawar pointed out how the Serum Institute's vaccine has proved effective for many diseases, including COVID, and how big their contribution is.
The National Technical Advisory Group for Immunisation (NTAGI) has recommended introduction of The quadrivalent Human Papilloma Virus (qHPV) vaccine in the Universal Immunization Programme (UIP) with a one-time catch-up for 9-14 year-old adolescent girls followed with routine introduction
The world's largest vaccine manufacturer, the Serum Institute of India Private Ltd (SII), is joining a growing Coalition for Epidemic Preparedness Innovations (CEPI) network of vaccine producers in the Global South to support more rapid, agile, and equitable responses to future public health
As malaria vaccine developed by the University of Oxford and the Serum Institute of India (SII) has been recommended for use by the World Health Organisation (WHO), SII chief Adar Poonawalla said that the combined efforts of both of them have come to fruition.
"As the first conjugate vaccine to safeguard against the five predominant causes of this deadly disease, MenFive® offers hope for a future free from annual outbreaks and epidemics in the African meningitis belt. It is a big moment as we, together, pave the way towards a healthier Africa